China NMPA Inspection - Guangdong Baihe Medical Technology Co., Ltd - October 11, 2016

An official report, published on October 11, 2016, by the National Medical Products Administration (NMPA), highlighted the outcomes of an unannounced inspection conducted at Guangdong Baihe Medical Technology Co., Ltd. While specific inspection dates were not disclosed, the report detailed serious non-compliance issues within the company's operations. The primary findings indicated that Guangdong Baihe Medical Technology Co., Ltd.'s actions did not align with the stringent requirements of the Good Manufacturing Practice for Medical Devices, which serves as the fundamental regulatory framework for medical device production quality. Critically, the inspection uncovered significant deficiencies within the company's overall quality management system, pointing to systemic issues in maintaining proper manufacturing controls and standards. Consequently, the Guangdong Provincial Food and Drug Administration has issued a directive, ordering Guangdong Baihe Medical Technology Co., Ltd. to rectify all identified deficiencies within a stipulated period. This action emphasizes the regulatory body's commitment to upholding product safety and quality in the medical device sector and ensures manufacturers adhere to established operational benchmarks.